These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10522787)

  • 1. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.
    Rhalem A; Sahibi H; Lasri S; Jaffe CL
    Vet Immunol Immunopathol; 1999 Oct; 71(1):69-76. PubMed ID: 10522787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western blot analysis of Leishmania infantum antigens using sera from pentamidine-treated dogs.
    Lasri S; Sahibi H; Natami A; Rhalem A
    Vet Immunol Immunopathol; 2003 Jan; 91(1):13-8. PubMed ID: 12507845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.
    Rhalem A; Sahibi H; Guessous-Idrissi N; Lasri S; Natami A; Riyad M; Berrag B
    Vet Parasitol; 1999 Mar; 81(3):173-84. PubMed ID: 10190861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens.
    Teixeira MC; Oliveira GG; Santos PO; Bahiense TC; da Silva VM; Rodrigues MS; Larangeira DF; Dos-Santos WL; Pontes-de-Carvalho LC
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):182-9. PubMed ID: 21537678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.
    Todolí F; Galindo I; Gómez-Sebastián S; Pérez-Filgueira M; Escribano JM; Alberola J; Rodríguez-Cortés A
    Am J Trop Med Hyg; 2010 May; 82(5):795-800. PubMed ID: 20439957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoproteomic approach to identifying immunoreactive proteins in
    Rashidi S; Mojtahedi Z; Shahriari B; Kalantar K; Ghalamfarsa G; Mohebali M; Hatam G
    Pathog Glob Health; 2019 May; 113(3):124-132. PubMed ID: 31099725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on the diagnosis technology of canine visceral leishmaniasis].
    Ding D; Wang JY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Oct; 30(5):406-10. PubMed ID: 23484286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs.
    Bourdoiseau G; Bonnefont C; Hoareau E; Boehringer C; Stolle T; Chabanne L
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):21-30. PubMed ID: 9437823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic components of partially purified antigens of Leishmania donovani infantum recognized by sera from dogs with asymptomatic or active visceral leishmaniasis.
    Da Costa JM; Neogy AB; Vouldoukis I; Silva ML; Gentilini M; Monjour L
    Am J Trop Med Hyg; 1996 Nov; 55(5):511-5. PubMed ID: 8940982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.
    Gómez-Ochoa P; Castillo JA; Gascón M; Zarate JJ; Alvarez F; Couto CG
    Vet J; 2009 Feb; 179(2):259-63. PubMed ID: 18023375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.